Sponsors (8)
The bill directs modest, multi‑year federal investment to expand research, provider training, outreach, reporting, and interagency coordination to improve perimenopause and menopause care—particularly for underserved populations—while creating modest new federal spending, administrative responsibilities, and risks that limited funding and eligibility rules may blunt national impact or equitable access.
Mid‑life women nationwide will gain improved diagnosis, treatment options, and access to evidence‑based guidance for perimenopause and menopause, improving care and potentially reducing untreated symptoms and complications.
Researchers and health systems will get expanded, NIH‑ and HHS‑backed research funding and reporting to fill evidence gaps on menopause, guiding future studies, treatment recommendations, and policy.
Clinicians, trainees, and the clinical workforce will receive new training programs, fellowships, continuing education, and technical assistance to build capacity for diagnosing and treating menopausal conditions.
Taxpayers will fund new programs and reports (multiple authorizations across the bill), increasing federal spending and adding modest budgetary pressure that may require offsets or compete with other priorities.
The authorized funding levels are relatively modest and may be insufficient to achieve broad, nationwide workforce and service changes, limiting benefits especially where needs are greatest.
Grant and eligibility requirements may advantage well‑resourced academic centers and institutions able to navigate federal grants, leaving smaller clinics, community groups, and some rural providers with limited access to funds.
Based on analysis of 7 sections of legislative text.
Directs NIH and HHS to expand menopause and mid‑life women’s health research, run a national education campaign, fund training programs, and create Centers of Excellence, with multiyear authorizations.
Official title: To improve menopause care and mid-life women's health, and for other purposes.
Introduced June 2, 2026 by Yvette Diane Clarke · Last progress June 2, 2026
Creates a coordinated federal program to expand research, awareness, training, and clinical capacity for perimenopause, menopause, post‑menopause, and mid‑life women’s health. The bill directs NIH to lead and fund research, requires HHS to run a national public education and outreach campaign, and establishes grant programs for workforce training and Centers of Excellence, with reporting and interagency coordination requirements. The measure authorizes multiyear grants and sets up annual funding authorizations for specific programs (education/outreach and training) through FY2027–FY2031, directs regular reports to Congress on progress and disparities, and requires coordination with VA, DOD, and other federal partners to improve clinical care, provider training, evidence generation, and public awareness for mid‑life women’s health issues.